相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancer
Monireh Davoodian et al.
MOLECULAR BIOLOGY REPORTS (2019)
The emerging role of substance P/neurokinin-1 receptor signaling pathways in growth and development of tumor cells
Hossein Javid et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis
Lufang Zhang et al.
CELL PROLIFERATION (2019)
The cross-talk between adipokines and miRNAs in health and obesity-mediated diseases
Ahmad Ghasemi et al.
CLINICA CHIMICA ACTA (2019)
MicroRNA-22 inhibits proliferation, invasion and metastasis of breast cancer cells through targeting truncated neurokinin-1 receptor and ERα
Xiaobin Liu et al.
LIFE SCIENCES (2019)
MicroRNA-mediated redox regulation modulates therapy resistance in cancer cells: clinical perspectives
Safieh Ebrahimi et al.
CELLULAR ONCOLOGY (2019)
Diagnostic, Prognostic, and Therapeutic Potencies of Circulating miRNAs in Acute Myocardial Infarction
Farshad Mirzavi et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2019)
miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer
Yu Zhou et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
mirDIP 4.1-integrative database of human microRNA target predictions
Tomas Tokar et al.
NUCLEIC ACIDS RESEARCH (2018)
Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P
Esra Nizam et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
RNA-binding protein PUM2 suppresses osteosarcoma progression via partly and competitively binding to STARD13 3 ' UTR with miRNAs
Ruixi Hu et al.
CELL PROLIFERATION (2018)
Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in endometrial cancer
Naghmeh Gharaee et al.
MOLECULAR BIOLOGY REPORTS (2018)
G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms
Pierre-Yves Jean-Charles et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)
Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis
Susmit Suvas
JOURNAL OF IMMUNOLOGY (2017)
Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations
Bernardo Leon Rapoport et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology
Ivy Ka Man Law et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)
The RNA-binding protein Musashi 1 stabilizes the oncotachykinin 1 mRNA in breast cancer cells to promote cell growth
George R. Nahas et al.
FASEB JOURNAL (2016)
Endostatin and irradiation modifies the activity of ADAM10 and neprilysin in breast cancer cells
Esra Arslan Aydemir et al.
MOLECULAR MEDICINE REPORTS (2016)
Substance P Prevents Vascular Endothelial Dysfunction in Metastatic Breast Carcinoma
Selvinaz Dalaklioglu et al.
PROTEIN AND PEPTIDE LETTERS (2016)
Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance
Prema Robinson et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Neuropeptide Levels as well as Neprilysin Activity Decrease in Renal Cell Carcinoma
Nuray Erin et al.
CANCER MICROENVIRONMENT (2016)
Activation of neuroimmune pathways increases therapeutic effects of radiotherapy on poorly differentiated breast carcinoma
Nuray Erin et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Neurokinin-1 activation affects EGFR related signal transduction in triple negative breast cancer
Ji-Gang Wang et al.
CELLULAR SIGNALLING (2015)
Biological and Pharmacological Aspects of the NK1-Receptor
Susana Garcia-Recio et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Transformer 2β and miR-204 regulate apoptosis through competitive binding to 3′ UTR of BCL2 mRNA
Y. Kuwano et al.
CELL DEATH AND DIFFERENTIATION (2015)
Thalidomide combined with irradiation alters the activity of two proteases
Ece Simsek et al.
MOLECULAR MEDICINE REPORTS (2015)
Aberrant Regulation and Function of MicroRNAs in Cancer
Brian D. Adams et al.
CURRENT BIOLOGY (2014)
The proinflammatory peptide substance P promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions
Pedro L. Rodriguez et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer
Miguel Munoz et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
TACHYKININS AND THEIR RECEPTORS: CONTRIBUTIONS TO PHYSIOLOGICAL CONTROL AND THE MECHANISMS OF DISEASE
Martin S. Steinhoff et al.
PHYSIOLOGICAL REVIEWS (2014)
Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer
Yunli Zhou et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Substance P Autocrine Signaling Contributes to Persistent HER2 Activation That Drives Malignant Progression and Drug Resistance in Breast Cancer
Susana Garcia-Recio et al.
CANCER RESEARCH (2013)
Walker 256 tumour cells increase substance P immunoreactivity locally and modify the properties of the blood-brain barrier during extravasation and brain invasion
Kate M. Lewis et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Involvement of substance P and the NK-1 receptor in cancer progression
Miguel Munoz et al.
PEPTIDES (2013)
An indirect role for the oncomir-519b in the expression of truncated neurokinin-1 in breast cancer cells
Peter Navarro et al.
EXPERIMENTAL CELL RESEARCH (2012)
Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2
Cristina Mayordomo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
NK-1 Receptor Antagonists: A New Generation of Anticancer Drugs
M. Munoz et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
The substance P/neurokinin-1 receptor system in lung cancer: Focus on the antitumor action of neurokinin-1 receptor antagonists
Miguel Munoz et al.
PEPTIDES (2012)
Activation of vagus nerve by semapimod alters substance P levels and decreases breast cancer metastasis
Nuray Erin et al.
REGULATORY PEPTIDES (2012)
MicroRNAs May Mediate the Down-Regulation of Neurokinin-1 Receptor in Chronic Bladder Pain Syndrome
Veronica Sanchez Freire et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Paravertebral anesthesia: how substance P and the NK-1 receptor could be involved in regional block and breast cancer recurrence
Miguel Munoz et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Tyrosine Kinase Receptor Transactivation Associated to G Protein-Coupled Receptors
Vanessa Almendro et al.
CURRENT DRUG TARGETS (2010)
SR140333 counteracts NK-1 mediated cell proliferation in human breast cancer cell line T47D
Wei-Qing Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells
Marina Chekulaeva et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Tachykinin receptor antagonists in clinical trials
Laura Quartara et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Neurokinin 1 Receptor Mediates Membrane Blebbing in HEK293 Cells through a Rho/Rho-associated Coiled-coil Kinase-dependent Mechanism
John Meshki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas
Toshimasa Akazawa et al.
JOURNAL OF NEUROCHEMISTRY (2009)
RE-1-silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cells
Bobby Y. Reddy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Targeted Tumor Diagnosis and Therapy with Peptide Hormones as Radiopharmaceuticals
Annette Beck-Sickinger et al.
Anti-Cancer Agents in Medicinal Chemistry (2008)
Cell motility through plasma membrane blebbing
Oliver T. Fackler et al.
JOURNAL OF CELL BIOLOGY (2008)
Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions
Jian-Ping Lai et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor
Jian-Ping Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters Substance P level
Nuray Erin et al.
REGULATORY PEPTIDES (2008)
Synergy between the RE-1 silencer of transcription and NFκB in the repression of the neurotransmitter gene TAC1 in human mesenchymal stem cells
Steven J. Greco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Neurokinin-1 receptors located in human retinoblastoma cell lines:: Antitumor action of its antagonist, L-732,138
Miguel Munoz et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells
Nuray Erin et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Tachykinin receptors antagonists: From research to clinic
Laura Quartara et al.
CURRENT DRUG TARGETS (2006)
The expression of neurokinin-1 and preprotachykinin-1 in breast cancer cells depends on the relative degree of invasive and metastatic potential
Tammy A. Castro et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides
HJ Patel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231
M Bigioni et al.
ANTI-CANCER DRUGS (2005)
Involvement of neutral endopeptidase in neoplastic progression
M Sumitomo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Anti-progressive effect of neutral endopeptidase 24.11 (NEP/CD10) on cervical carcinoma in vitro and in vivo
M Terauchi et al.
ONCOLOGY (2005)
Facilitating role of preprotachykinin-I gene in the integration of breast cancer cells within the stromal compartment of the bone marrow: A model of early cancer progression
G Rao et al.
CANCER RESEARCH (2004)
Tachykinins and tachykinin receptors:: Structure and activity relationships
TA Almeida et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Recycling and resensitization of the neurokinin 1 receptor - Influence of agonist concentration and Rab GTPases
D Roosterman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs
K Lang et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells
TL Drell et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer
H Friess et al.
LABORATORY INVESTIGATION (2003)
Potential of substance P antagonists as antiemetics
P Diemunsch et al.
DRUGS (2000)
Epidermal growth factor receptor transactivation mediates substance P-induced mitogenic responses in U-373 MG cells
I Castagliuolo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Human stem cells express substance P gene and its receptor
Y Li et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2000)
Increased expression of preprotachykinin-1 and neurokinin receptors in human breast cancer cells:: Implications for bone marrow metastasis
D Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
